Reference health
Cannabidiol – Recent Advances
64/64 checkable references clean · checked 2026-07-22
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
3 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 64 checked references that resolve
resolves10.1016/S0014-2999(02)02624-9
(−)-Cannabidiol antagonizes cannabinoid receptor agonists and noradrenaline in the mouse vas deferens
resolves10.1007/s10681-004-4756-9
Pharmacological and therapeutic targets for Δ9 tetrahydrocannabinol and cannabidiol
resolves10.1016/j.mehy.2005.08.026
A tale of two cannabinoids: The therapeutic rationale for combining tetrahydrocannabinol and cannabidiol
resolves10.1016/S0009-3084(02)00144-5
Cannabidiol: an overview of some chemical and pharmacological aspects. Part I: chemical aspects
resolves10.1038/sj.bjp.0707133
Cannabidiol displays unexpectedly high potency as an antagonist of CB<sub>1</sub>and CB<sub>2</sub>receptor agonists<i>in vitro</i>
resolves10.1073/pnas.0511232103
Inhibition of an equilibrative nucleoside transporter by cannabidiol: A mechanism of cannabinoid immunosuppression
resolves10.1073/pnas.160105897
The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis
resolves10.1161/01.STR.0000163083.59201.34
Cannabidiol Prevents Cerebral Infarction Via a Serotonergic 5-Hydroxytryptamine
<sub>1A</sub>
Receptor–Dependent Mechanism
resolves10.1016/0014-2999(95)00271-L
Neuroprotective and antioxidant activities of HU-211, a novel NMDA receptor antagonist
resolves10.1073/pnas.95.14.8268
Cannabidiol and (−)Δ
<sup>9</sup>
-tetrahydrocannabinol are neuroprotective antioxidants
resolves10.1124/jpet.105.085779
Comparison of Cannabidiol, Antioxidants, and Diuretics in Reversing Binge Ethanol-Induced Neurotoxicity
resolves10.1016/S0040-4039(00)98518-6
Boron triflouride etherate on alimina - a modified Lewis acid reagent.
resolves10.1021/ol063022k
Synthesis of (-)-Δ<sup>9</sup>-<i>trans</i>-Tetrahydrocannabinol: Stereocontrol via Mo-Catalyzed Asymmetric Allylic Alkylation Reaction
resolves10.1016/j.ejphar.2004.01.023
6ʺ-Azidohex-2ʺ-yne-cannabidiol: a potential neutral, competitive cannabinoid CB1 receptor antagonist
resolves10.1124/mol.105.021089
A Cannabinoid Quinone Inhibits Angiogenesis by Targeting Vascular Endothelial Cells
resolves10.1158/1535-7163.MCT-06-0039
HU-331, a novel cannabinoid-based anticancer topoisomerase II inhibitor
resolves10.1039/b416943c
Enantiomeric cannabidiol derivatives: synthesis and binding to cannabinoid receptors
resolves10.1038/sj.bjp.0704327
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide
resolves10.1016/j.ejphar.2004.10.049
(+)-Cannabidiol analogues which bind cannabinoid receptors but exert peripheral activity only
resolves10.1021/jm050709m
New Cannabidiol Derivatives: Synthesis, Binding to Cannabinoid Receptor, and Evaluation of Their Antiinflammatory Activity
resolves10.1002/jps.20766
Precipitation Complexation Method Produces Cannabidiol/β-Cyclodextrin Inclusion Complex Suitable for Sublingual Administration of Cannabidiol
resolves10.1007/s00210-006-0033-x
Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors
resolves10.1016/j.jneuroim.2004.10.003
The nonpsychoactive component of marijuana cannabidiol modulates chemotaxis and IL-10 and IL-12 production of murine macrophages both in vivo and in vitro
resolves10.1124/jpet.103.051961
Evidence for Cannabinoid Receptor-Dependent and -Independent Mechanisms of Action in Leukocytes
resolves10.1007/BF00915771
Analgesic and antiinflammatory activity of constituents ofCannabis sativa L.
resolves10.1016/0192-0561(91)90160-9
Marijuana components stimulate human peripheral blood mononuclear cell secretion of interferon-gamma and suppress interleukin-1 alpha in vitro
resolves10.1016/S0162-3109(98)00041-1
Δ9 Tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells
resolves10.1002/cpt1976196782
Effeets of marijuana extract and tetrahydrocannabinol on electroencephalographic sleep patterns
resolves10.1097/01.jcp.0000125688.05091.8f
Effect of Δ-9-Tetrahydrocannabinol and Cannabidiol on Nocturnal Sleep and Early-Morning Behavior in Young Adults
resolves10.1016/j.febslet.2006.04.102
Cannabidiol, a constituent of <i>Cannabis sativa</i>, modulates sleep in rats
resolves10.1126/science.276.5321.2048
Cannabinoid and Heroin Activation of Mesolimbic Dopamine Transmission by a Common µ
<sub>1</sub>
Opioid Receptor Mechanism
resolves10.1038/sj.bjp.0702753
Modulation by fluoxetine of striatal dopamine release following Δ<sup>9</sup>‐tetrahydrocannabinol: a microdialysis study in conscious rats
resolves10.1016/S0024-3205(04)00291-7
Cannabidiol increases Fos expression in the nucleus accumbens but not in the dorsal striatum
resolves10.1016/j.nbd.2004.11.009
Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: Relevance to Parkinson's disease
resolves10.1016/j.brainres.2006.11.063
Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: Importance of antioxidant and cannabinoid receptor-independent properties
resolves10.1111/j.1471-4159.2003.02327.x
Neuroprotective effect of cannabidiol, a non‐psychoactive component from<i>Cannabis sativa</i>, on β‐amyloid‐induced toxicity in PC12 cells
resolves10.1007/s00109-005-0025-1
The marijuana component cannabidiol inhibits β-amyloid-induced tau protein hyperphosphorylation through Wnt/β-catenin pathway rescue in PC12 cells
resolves10.1016/j.neulet.2006.01.047
Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in β-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-κB involvement
resolves10.1016/S0304-3940(03)00569-X
Post-ischemic treatment with cannabidiol prevents electroencephalographic flattening, hyperlocomotion and neuronal injury in gerbils
resolves10.1097/00001756-200410250-00016
Cannabidiol prevents infarction via the non-CB1 cannabinoid receptor mechanism
resolves10.1016/j.neuropharm.2006.11.005
Repeated treatment with cannabidiol but not Δ9-tetrahydrocannabinol has a neuroprotective effect without the development of tolerance
resolves10.1080/08916930500356674
Cannabidiol lowers incidence of diabetes in non-obese diabetic mice
resolves10.2353/ajpath.2006.050500
Neuroprotective and Blood-Retinal Barrier-Preserving Effects of Cannabidiol in Experimental Diabetes
resolves10.1007/s00213-004-1825-7
Effect of low doses of ?9-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in rats
resolves10.1007/s00213-003-1571-2
Effect of cannabinoids on lithium-induced vomiting in the Suncus murinus (house musk shrew)
resolves10.1016/j.physbeh.2005.08.045
Delta-9-tetrahydrocannabinol and cannabidiol, but not ondansetron, interfere with conditioned retching reactions elicited by a lithium-paired context in Suncus murinus: An animal model of anticipatory nausea and vomiting
resolves10.1002/art.20050
A novel synthetic, nonpsychoactive cannabinoid acid (HU‐320) with antiinflammatory properties in murine collagen‐induced arthritis
resolves10.1016/S0006-2952(00)00492-5
Serum-dependent effects of tamoxifen and cannabinoids upon C6 glioma cell viability
resolves10.1124/jpet.103.061002
Antitumor Effects of Cannabidiol, a Nonpsychoactive Cannabinoid, on Human Glioma Cell Lines
resolves10.1124/jpet.106.105247
Antitumor Activity of Plant Cannabinoids with Emphasis on the Effect of Cannabidiol on Human Breast Carcinoma
resolves10.1007/s00018-006-6156-x
The non-psychoactive cannabidiol triggers caspase activation and oxidative stress in human glioma cells
resolves10.1080/1042819031000103917
γ-Irradiation Enhances Apoptosis Induced by Cannabidiol, a Non-psychotropic Cannabinoid, in Cultured HL-60 Myeloblastic Leukemia Cells
resolves10.1124/mol.106.023937
Cannabidiol-Induced Apoptosis in Human Leukemia Cells: A Novel Role of Cannabidiol in the Regulation of p22 and Nox4 Expression
resolves10.1038/sj.bjp.0706134
Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor‐independent mechanism
resolves10.1016/j.bcp.2005.12.033
The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells
resolves10.1124/jpet.105.098541
Characterization of P-glycoprotein Inhibition by Major Cannabinoids from Marijuana
The 3 references without a DOI — listed, not checked
no DOI — not checkedA. W. Zuardi F. S. Guimaraes V. M. C. Guimaraes E. A. Del Bel
no DOI — not checkedL.Weiss submitted for publication.
no DOI — not checkede_1_2_1_58_2
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1002/cbdv.200790147"><img src="https://citestamp.com/citestamped/10.1002/cbdv.200790147/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1002/cbdv.200790147)